γ-Protocadherin structural diversity and functional implications
- Columbia University, United States
Abstract
Stochastic cell-surface expression of α-, β-, and γ-clustered protocadherins (Pcdhs) provides vertebrate neurons with single-cell identities that underlie neuronal self-recognition. Here we report crystal structures of ectodomain fragments comprising cell-cell recognition regions of mouse γ-Pcdhs γA1, γA8, γB2, and γB7 revealing trans-homodimers, and of C-terminal ectodomain fragments from γ-Pcdhs γA4 and γB2, which depict cis-interacting regions in monomeric form. Together these structures span the entire Pcdhγ ectodomain. The trans-dimer structures reveal determinants of Pcdh-γ isoform-specific homophilic recognition. We identified and structurally mapped cis-dimerization mutations to the C-terminal ectodomain structures. Biophysical studies showed that Pcdh ectodomains from γB-subfamily isoforms formed cis dimers, whereas γA isoforms did not, but both γA and γB isoforms could interact in cis with α-Pcdhs. Together, these data show how interaction specificity is distributed over all domains of the γ-Pcdh trans interface, and suggest that subfamily- or isoform-specific cis-interactions may play a role in the Pcdh-mediated neuronal self-recognition code.
Data availability
-
Protocadherin gamma A1 extracellular cadherin domains 1-4Publicly available at the RCSB Protein Data Bank (accession no. 5SZL).
-
Protocadherin gamma A8 extracellular cadherin domains 1-4Publicly available at the RCSB Protein Data Bank (accession no. 5SZM).
-
Protocadherin gamma A9 extracellular cadherin domains 1-5Publicly available at the RCSB Protein Data Bank (accession no. 5SZN).
-
Protocadherin Gamma B7 extracellular cadherin domains 1-4 P41212 crystal formPublicly available at the RCSB Protein Data Bank (accession no. 5SZO).
-
Protocadherin Gamma B7 extracellular cadherin domains 1-4 P21 crystal formPublicly available at the RCSB Protein Data Bank (accession no. 5SZP).
-
Protocadherin gamma A4 extracellular cadherin domains 3-6Publicly available at the RCSB Protein Data Bank (accession no. 5SZQ).
-
Protocadherin Gamma B2 extracellular cadherin domains 3-6Publicly available at the RCSB Protein Data Bank (accession no. 5SZR).
-
Protocadherin Gamma B2 extracellular cadherin domains 1-5Publicly available at the RCSB Protein Data Bank (accession no. 5T9T).
-
Structure of mouse clustered PcdhgA1 EC1-3Publicly available at the RCSB Protein Data Bank (accession no. 4ZI9).
-
Crystal Structure of Protocadherin Gamma A8 EC1-3Publicly available at the RCSB Protein Data Bank (accession no. 4ZPS).
-
Protocadherin alpha 7 extracellular cadherin domains 1-5Publicly available at the RCSB Protein Data Bank (accession no. 5DZV).
Article and author information
Author details
Funding
National Institutes of Health (R01GM107571)
- Tom Maniatis
- Lawrence Shapiro
Howard Hughes Medical Institute (R01GM062270)
- Fabiana Bahna
- Barry Honig
National Science Foundation (MCB-1412472)
- Barry Honig
Howard Hughes Medical Institute
- Fabiana Bahna
- Göran Ahlsén
- Barry Honig
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2016, Goodman et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,299
- views
-
- 487
- downloads
-
- 57
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
γ-Protocadherin structural diversity and functional implications
eLife 5:e20930.
https://doi.org/10.7554/eLife.20930
Further reading
-
- Structural Biology and Molecular Biophysics
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.
-
- Structural Biology and Molecular Biophysics
SCARF1 (scavenger receptor class F member 1, SREC-1 or SR-F1) is a type I transmembrane protein that recognizes multiple endogenous and exogenous ligands such as modified low-density lipoproteins (LDLs) and is important for maintaining homeostasis and immunity. But the structural information and the mechanisms of ligand recognition of SCARF1 are largely unavailable. Here, we solve the crystal structures of the N-terminal fragments of human SCARF1, which show that SCARF1 forms homodimers and its epidermal growth factor (EGF)-like domains adopt a long-curved conformation. Then, we examine the interactions of SCARF1 with lipoproteins and are able to identify a region on SCARF1 for recognizing modified LDLs. The mutagenesis data show that the positively charged residues in the region are crucial for the interaction of SCARF1 with modified LDLs, which is confirmed by making chimeric molecules of SCARF1 and SCARF2. In addition, teichoic acids, a cell wall polymer expressed on the surface of gram-positive bacteria, are able to inhibit the interactions of modified LDLs with SCARF1, suggesting the ligand binding sites of SCARF1 might be shared for some of its scavenging targets. Overall, these results provide mechanistic insights into SCARF1 and its interactions with the ligands, which are important for understanding its physiological roles in homeostasis and the related diseases.
